drugset / Trial / NCT00490815

Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema

NCT00490815

Phase 3 Completed 37 enrolled Alimera Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the pharmacokinetics, safety and efficacy of an intravitreal insert of fluocinolone acetonide for the treatment of diabetic macular edema

Timeline

Start
2007-08
Primary completion
2009-09
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject fluocinolone acetonide Small molecule 0.2 mg Intravitreal
Subject fluocinolone acetonide Small molecule 0.5 mg Intravitreal